Mimedx (MDXG) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
MDXG slides 5.3% to $4.43, a 1-month low on 2.5x normal volume. Closed at $4.43, -5.34% vs the prior close of $4.68. Day range $4.40–$4.66, opened at $4.66.
MDXG daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MDXG slides 5.3% to $4.43, a 1-month low on 2.5x normal volume
- Closed at $4.43, -5.34% vs the prior close of $4.68. Day range $4.40–$4.66, opened at $4.66.
- Volume was 2.73M shares, 2.5x its 50-day average of 1.09M — unusually heavy trading.
- Price is -2.7% vs its 50-day average ($4.55) and +1.0% vs its 200-day average ($4.39).
- 52-week range $3.03–$7.97; today's close sits at 28% of that range, 44.4% below the 52-week high.
Oct 15, 2026 — MDXG dips 0.4% to $4.68
- Closed at $4.68, -0.43% vs the prior close of $4.70. Day range $4.66–$4.88, opened at $4.76.
- Volume was 1.33M shares, 1.2x its 50-day average of 1.09M.
- Price is +3.0% vs its 50-day average ($4.55) and +6.4% vs its 200-day average ($4.40).
- 52-week range $3.03–$7.97; today's close sits at 33% of that range, 41.3% below the 52-week high.
Oct 14, 2026 — MDXG ends flat (+0.2%) to $4.70
- Closed at $4.70, +0.21% vs the prior close of $4.69. Day range $4.64–$4.74, opened at $4.65.
- Volume was 1.64M shares, 1.5x its 50-day average of 1.10M.
- Price is +3.6% vs its 50-day average ($4.54) and +6.6% vs its 200-day average ($4.41).
- 52-week range $3.03–$7.97; today's close sits at 34% of that range, 41.0% below the 52-week high.
Oct 13, 2026 — MDXG dips 2.9% to $4.69
- Closed at $4.69, -2.90% vs the prior close of $4.83. Day range $4.68–$4.87, opened at $4.86.
- Volume was 972.30K shares, 0.9x its 50-day average of 1.11M.
- Price is +3.6% vs its 50-day average ($4.53) and +6.1% vs its 200-day average ($4.42).
- 52-week range $3.03–$7.97; today's close sits at 34% of that range, 41.2% below the 52-week high.
Oct 12, 2026 — MDXG jumps 3.4% to $4.83, 3 up days in a row
- Closed at $4.83, +3.43% vs the prior close of $4.67. Day range $4.63–$4.84, opened at $4.68.
- Volume was 625.60K shares, 0.5x its 50-day average of 1.16M — lighter than usual.
- Price is +6.9% vs its 50-day average ($4.52) and +9.0% vs its 200-day average ($4.43).
- 52-week range $3.03–$7.97; today's close sits at 36% of that range, 39.4% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — MDXG rises 1.1% to $4.67
- Closed at $4.67, +1.08% vs the prior close of $4.62. Day range $4.58–$4.70, opened at $4.58.
- Volume was 391.10K shares, 0.3x its 50-day average of 1.28M — lighter than usual.
- Price is +3.7% vs its 50-day average ($4.50) and +5.1% vs its 200-day average ($4.44).
- 52-week range $3.03–$7.97; today's close sits at 33% of that range, 41.4% below the 52-week high.
Oct 8, 2026 — MDXG ends flat (+0.2%) to $4.62
- Closed at $4.62, +0.22% vs the prior close of $4.61. Day range $4.48–$4.63, opened at $4.58.
- Volume was 1.08M shares, 0.8x its 50-day average of 1.28M.
- Price is +2.7% vs its 50-day average ($4.50) and +3.7% vs its 200-day average ($4.45).
- 52-week range $3.03–$7.97; today's close sits at 32% of that range, 42.0% below the 52-week high.
Oct 7, 2026 — MDXG ends flat (-0.2%) to $4.61
- Closed at $4.61, -0.22% vs the prior close of $4.62. Day range $4.57–$4.68, opened at $4.58.
- Volume was 821.10K shares, 0.6x its 50-day average of 1.29M.
- Price is +2.7% vs its 50-day average ($4.49) and +3.2% vs its 200-day average ($4.47).
- 52-week range $3.03–$7.97; today's close sits at 32% of that range, 42.2% below the 52-week high.
Oct 6, 2026 — MDXG rises 1.5% to $4.62
- Closed at $4.62, +1.54% vs the prior close of $4.55. Day range $4.48–$4.65, opened at $4.59.
- Volume was 1.05M shares, 0.8x its 50-day average of 1.29M.
- Price is +3.0% vs its 50-day average ($4.48) and +3.1% vs its 200-day average ($4.48).
- 52-week range $3.03–$7.97; today's close sits at 32% of that range, 42.0% below the 52-week high.
Oct 5, 2026 — MDXG dips 0.9% to $4.55, 5 down days in a row
- Closed at $4.55, -0.87% vs the prior close of $4.59. Day range $4.55–$4.70, opened at $4.58.
- Volume was 894.70K shares, 0.7x its 50-day average of 1.28M.
- Price is +1.6% vs its 50-day average ($4.48) and +1.3% vs its 200-day average ($4.49).
- 52-week range $3.03–$7.97; today's close sits at 31% of that range, 42.9% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — MDXG dips 1.1% to $4.59, 4 down days in a row
- Closed at $4.59, -1.08% vs the prior close of $4.64. Day range $4.49–$4.69, opened at $4.69.
- Volume was 1.37M shares, 1.1x its 50-day average of 1.27M.
- Price is +2.7% vs its 50-day average ($4.47) and +1.9% vs its 200-day average ($4.51).
- 52-week range $3.03–$7.97; today's close sits at 32% of that range, 42.4% below the 52-week high.
- That makes 4 straight losses.
MDXG latest news & SEC filings
Every SEC filing by or about MDXG in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 4, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 11, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $64.36M (prior year $98.61M) (-34.7% vs Jun 30, 2025)
- Net income: -$14.84M (prior year $9.62M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.10 (prior year $0.06) (loss widened vs Jun 30, 2025)
Things to know before you trade MDXG
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: Apr 29, 2026, Feb 25, 2026, Oct 29, 2025. Based on that rhythm, the next report is likely around Oct 28, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.35% (largest 5.3%).
- Liquidity: about 1.12M shares (≈$4.95M) trade per day on average.
- 52-week position: $4.43 vs a range of $3.03–$7.97 (28% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 4 sales; latest: Kimberly Maersk-Moller sold 58,300 shares on Nov 6, 2025.
- Latest filings: 8-K Oct 16, 2026; 8-K Jul 29, 2026; 10-Q Jul 29, 2026.
- Share count: 145.76M shares outstanding (Jul 23, 2026), -1.5% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
MDXG market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.66 | 4.66 | 4.40 | 4.43 | 2.73M |
| Oct 15, 2026 | 4.76 | 4.88 | 4.66 | 4.68 | 1.33M |
| Oct 14, 2026 | 4.65 | 4.74 | 4.64 | 4.70 | 1.64M |
| Oct 13, 2026 | 4.86 | 4.87 | 4.68 | 4.69 | 972.30K |
| Oct 12, 2026 | 4.68 | 4.84 | 4.63 | 4.83 | 625.60K |
| Oct 9, 2026 | 4.58 | 4.70 | 4.58 | 4.67 | 391.10K |
| Oct 8, 2026 | 4.58 | 4.63 | 4.48 | 4.62 | 1.08M |
| Oct 7, 2026 | 4.58 | 4.68 | 4.57 | 4.61 | 821.10K |
| Oct 6, 2026 | 4.59 | 4.65 | 4.48 | 4.62 | 1.05M |
| Oct 5, 2026 | 4.58 | 4.70 | 4.55 | 4.55 | 894.70K |
| Oct 2, 2026 | 4.69 | 4.69 | 4.49 | 4.59 | 1.37M |
| Oct 1, 2026 | 4.65 | 4.68 | 4.57 | 4.64 | 1.19M |
| Sep 30, 2026 | 4.70 | 4.70 | 4.57 | 4.66 | 1.03M |
| Sep 29, 2026 | 4.65 | 4.69 | 4.58 | 4.67 | 901.20K |
| Sep 28, 2026 | 4.66 | 4.73 | 4.55 | 4.68 | 881.30K |
| Sep 25, 2026 | 4.71 | 4.71 | 4.40 | 4.67 | 1.46M |
| Sep 24, 2026 | 4.81 | 4.82 | 4.66 | 4.71 | 1.02M |
| Sep 23, 2026 | 4.93 | 4.99 | 4.67 | 4.77 | 1.00M |
| Sep 22, 2026 | 4.81 | 4.94 | 4.78 | 4.93 | 1.03M |
| Sep 21, 2026 | 4.79 | 4.84 | 4.75 | 4.81 | 915.90K |
About Mimedx
Mimedx (MDXG) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in MARIETTA, GA. Fiscal year ends December 31. SEC CIK 1376339.
MDXG board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| James L Bierman | Director | Jun 12, 2026 |
| William A Hawkins | Director | Jun 12, 2026 |
| Todd Newton | Director | Jun 12, 2026 |
| Tiffany Olson | Director | Jun 12, 2026 |
| Dorothy E Puhy | Director | Jun 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Joseph H Capper | Chief Executive Officer | Mar 6, 2026 |
| Rice Doug | Chief Financial Officer | Jul 7, 2026 |
| William Frank Iv Hulse | General Counsel and CAO | Mar 17, 2026 |
| Kimberly Maersk-Moller | Chief Commercial Officer | Jun 25, 2026 |
| Ricci S Whitlow | Chief Operating Officer | Mar 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Nov 6, 2025 | Kimberly Maersk-Moller | Sale | 58,300 | $7.42 |
| Nov 6, 2025 | Kimberly Maersk-Moller | Sale | 58,300 | $7.42 |
| Nov 6, 2025 | Kimberly Maersk-Moller | Sale | 58,300 | $7.42 |
| Nov 6, 2025 | Kimberly Maersk-Moller | Sale | 58,300 | $7.42 |
MDXG financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $418.63M | $48.58M | 0.32 | $74.00M |
| Dec 31, 2024 | $348.88M | $42.42M | 0.28 | $66.20M |
| Dec 31, 2023 | $321.48M | $58.23M | 0.37 | $26.77M |
| Dec 31, 2022 | $267.84M | $-30.20M | -0.33 | $-17.89M |
| Dec 31, 2021 | $242.02M | $-10.29M | -0.15 | $-1.98M |
Latest balance sheet: total assets $281.00M, total liabilities $65.00M, cash $135.84M (as of Jun 30, 2026).
MDXG earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $4.23 |
| Apr 29, 2026 | 8-K Item 2.02 (results) | $3.09 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $5.28 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $7.19 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $6.52 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $6.88 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $8.01 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $5.69 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| Apr 30, 2024 | 8-K Item 2.02 (results) | — |
| Feb 28, 2024 | 8-K Item 2.02 (results) | — |
| Oct 30, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MDXG
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.